---
title: "CNSP.US (CNSP.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CNSP.US/news.md"
symbol: "CNSP.US"
name: "CNSP.US"
parent: "https://longbridge.com/zh-HK/quote/CNSP.US.md"
datetime: "2026-03-15T21:26:43.875Z"
locales:
  - [en](https://longbridge.com/en/quote/CNSP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CNSP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CNSP.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/CNSP.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/CNSP.US/news.md)


# CNSP.US (CNSP.US) — 相關新聞

### [CNS Pharmaceuticals launches strategic pivot, names new executive team and begins asset search](https://longbridge.com/zh-HK/news/278724282.md)
*2026-03-11T12:43:00.000Z*
> CNS Pharmaceuticals has announced a strategic pivot with a new executive team and a search for high-value neurology and 

### [CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline | CNSP Stock News](https://longbridge.com/zh-HK/news/278722622.md)
*2026-03-11T04:35:33.000Z*
> CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline | C

### [CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation | CNSP Stock News](https://longbridge.com/zh-HK/news/276129382.md)
*2026-02-17T05:25:00.000Z*
> CNS Pharmaceuticals has appointed key executives to enhance its leadership team, including Rami Levin as President and C

### [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://longbridge.com/zh-HK/news/275753265.md)
*2026-02-12T12:05:51.000Z*
> In Thursday's pre-market session, several health care stocks experienced significant movements. NovoCure (NVCR) surged 2

### [CraniUS Therapeutics secures $20M in Series B funding for NeuroPASS™ platform development to penetrate blood-brain barrier.](https://longbridge.com/zh-HK/news/273994663.md)
*2026-01-28T12:52:30.000Z*
> CraniUS Therapeutics LLC, a private neurotechnology company, recently disclosed that it has secured $20 million in Serie

### [07:50 ET
			
			
				CraniUS Therapeutics Closes $20 Million Series B Round to Advance NeuroPASS™ Platform Towards Future Commercialization](https://longbridge.com/zh-HK/news/273992072.md)
*2026-01-28T12:52:04.000Z*
> CraniUS Therapeutics has successfully closed a $20 million Series B financing round to advance its NeuroPASS™ platform, 

### [CNS Pharmaceuticals Inc. Outlines Strategy to Sharpen Focus, Optimize Pipeline, and Align Capital Allocation for Long-Term Value Creation](https://longbridge.com/zh-HK/news/273859436.md)
*2026-01-27T14:51:03.000Z*
### [12 Health Care Stocks Moving In Thursday's Intraday Session](https://longbridge.com/zh-HK/news/272729633.md)
*2026-01-15T17:05:42.000Z*
> In Thursday's intraday session, several health care stocks experienced significant movements. Notable gainers included A

### [CNS Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for CEO and President Rami Levin](https://longbridge.com/zh-HK/news/271364140.md)
*2026-01-02T22:00:33.000Z*